At 69, Hoyt “Corky” Ball knew something was wrong when his right hand began to tremble uncontrollably. His primary doctor ruled out Parkinson’s, but the prescribed medication failed to alleviate his symptoms.
As Sarah Custer gasped for air in the back of a van on U.S. 127, all she could think about were her children — especially the one inside her. If Sarah couldn’t breathe, neither could Isabel.
Most high school sophomores begin the school year eager to reconnect with friends, pick back up in their extracurricular activities and begin challenging themselves with new classes. More importantly, they are excited to no longer be a freshman.
In many ways, Treasure Newton is your typical 17-year-old. She loves hanging out with her friends and family, trying new recipes and doing her makeup. But unlike most teens, she knows exactly what she wants to be when she grows up.
Calvin Mabson had been getting routine annual lung cancer screenings for two decades. As a lifelong smoker, the retired Richmond resident understood that with each passing year, the screening results could bring bad news.
“We thought it was a spider bite — we didn’t think much of it.” That’s what Richmond residents Dynae Utz and her husband, L.T., thought when they first saw the lump on their 6-year-old son Lewis' leg. Then the lump got bigger, to the point where surgery was needed to remove it.
UK is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of lecanemab (investigational antibody) in people who have no cognitive symptoms of Alzheimer’s disease (AD), but in whom biomarker tests indicate amyloid is present in the brain, known as “preclinical” AD.
The motivation driving the work of Pete Nelson, M.D., Ph.D., is personal. His grandmother, Sylvia Becker, died with Alzheimer's disease, and he says his mother then grew terrified of developing the disease.
Chris Lyons is a details guy. In his exhibition of photographs on display outside the DanceBlue Kentucky Children's Hospital Hematology/Oncology Clinic, you see his appreciation for the details in buildings, patterns in nature and the shapes in light and shadow.
Despite the leaps and advances made in cancer treatments over the past few decades, sometimes patients still discover that they’ve exhausted all other available options.
